PMC:7275137 / 9412-9656 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T57","span":{"begin":74,"end":75},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"dergo protonation-based trapping in the lumen of the acidic vesicle. From a chemical standpoint, most drugs that demonstrate lysosomotropic properties are cationic substances that usually belong to the group of primary, secondary or tertiary am"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T57","span":{"begin":102,"end":107},"obj":"Chemical"},{"id":"T58","span":{"begin":202,"end":207},"obj":"Chemical"}],"attributes":[{"id":"A57","pred":"chebi_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A58","pred":"chebi_id","subj":"T58","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"dergo protonation-based trapping in the lumen of the acidic vesicle. From a chemical standpoint, most drugs that demonstrate lysosomotropic properties are cationic substances that usually belong to the group of primary, secondary or tertiary am"}